Related Experiment Video
Updated: Feb 16, 2026
Organoid-Derived Epithelial Monolayer: A Clinically Relevant In Vitro Model for Intestinal Barrier Function
Published on: July 29, 2021
Kras in Organoids
1CSHL Cancer Center, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11743.
Abstract:
Oncogenic Kras are genetic dependencies for the majority of pancreatic and colorectal adenocarcinomas; however, much remains to be understood regarding its tropism to these carcinomas. Recently developed organoid technology presents a more representative model culture system for pancreatic and colon epithelial tissues as well as better fostering the culture of nonimmortalized cells than two-dimensional culture. These advantages enable cancer researchers to directly compare tumor and normal tissue models to better study tumor initiation as well as therapeutic efficacy. Although in vivo models better model the complexity of multiple cell types, the organoid system allows for easier genetic manipulations and isolation of specific cell types. Furthermore, syngeneic orthotopically transplanted organoids recapitulate tumor histologically and gene expression of the tumors from which they were derived. Thus, organoids may extend the use of genetically engineered mouse models. These advantages of organoid cultures allow for many questions, including but not limited to studying the interaction between different cell types within a tumor and elucidating dependencies of Kras-driven tumors.
Insights
Organoid technology offers a superior model for studying Kras-driven pancreatic and colorectal cancers. This method allows for detailed analysis of tumor initiation and therapeutic strategies.
Area of Science:
- Oncology
- Cancer Biology
- Biotechnology
Background:
- Oncogenic Kras mutations are key drivers in pancreatic and colorectal adenocarcinomas.
- Understanding Kras tropism in these cancers is crucial for developing targeted therapies.
- Traditional 2D cultures have limitations in representing complex tumor microenvironments.
Purpose of the Study:
- To highlight the advantages of organoid technology in modeling Kras-driven cancers.
- To compare organoid models with traditional 2D and in vivo models.
- To explore the potential of organoids in studying tumor initiation and therapeutic efficacy.
Main Methods:
- Utilizing advanced organoid technology for pancreatic and colon epithelial tissues.
- Comparing organoid cultures with 2D cultures and in vivo models.
- Employing syngeneic orthotopic transplantation of organoids.
Main Results:
- Organoid technology provides a more representative culture system for non-immortalized cells.
- Organoids facilitate direct comparison of tumor and normal tissue models.
- Transplanted organoids accurately recapitulate tumor histology and gene expression.
Conclusions:
- Organoid cultures offer significant advantages for studying Kras-driven tumors.
- This technology enhances the investigation of tumor-cell interactions and dependencies.
- Organoids may extend the utility of genetically engineered mouse models in cancer research.
